Treatment of advanced cutaneous squamous cell carcinoma with cemiplimab in elderly multimorbid patients – a case series

Key Points

• The aim is to evaluate the effectiveness of cemiplimab in treating advanced cutaneous squamous cell carcinoma in elderly patients with multiple health conditions.
• Case series design focusing on elderly multimorbid patients
• Intervention involving cemiplimab administration for cancer treatment
• Assessment of patient outcomes and treatment responses
• Cemiplimab showed promising efficacy in reducing tumor size in elderly patients.
• Most patients tolerated the treatment well without significant adverse effects.
• Long-term follow-up demonstrated durable responses in several cases.

Abstract